Endothelin antagonist and beta receptor blocking agent as combined preparations
US6352992B1 · kind B1 · utility
11Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2000 |
| Grant date | Mar 5, 2002 |
| Priority date | — |
| Expiry date | Mar 20, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination of endothelin antagonists and beta-receptor blockers is described. The combination is suitable for controlling diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.